The Pistoia Alliance AbVance Project Reaches a Key Milestone with First Release of Antibody Structures into the Protein Data Bank
The AbVance project aims to accelerate biologics drug discovery by increasing knowledge of antibody structures in the public domain
Nearly 200 participants attended our 2017 Annual USA Conference, a record attendance which helped provide us with a great platform …
Medley Genomics and Transformative AI Selected as Winners in the 2017 Pistoia Alliance President’s Startup Challenge
Startups accelerating research into …
Lowering Barriers to R&D Innovation
We are a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D.
Our projects transform R&D innovation through pre-competitive collaboration. We bring together the key constituents to identify the root causes that lead to R&D inefficiencies. We develop best practices and technology pilots to overcome common obstacles.
Our members collaborate as equals on open projects that generate significant value for the worldwide life sciences community.
With the launch of our Interactive Project Portfolio Platform (IP3) we are embracing a new level of openness, access, and transparency around our idea-to-project process. The platform is open to the public to submit new ideas, comment and vote on proposed ideas, and monitor the progress of our projects.
Royal Society of Chemistry, London – 11th April 2018
45 delegates from 30 companies explored the dramatic increase in …
We’re pleased to announce the official release of our new UXLS Toolkit! Designed to provide valuable information about …
* A full list of our membership including individual members can be found here. (Last updated May 18 2018)
- AI/ML CoE Datathon for Repurposing Drugs for Rare Diseases
01 Oct 2018 - 31 Dec 2018,
- The Lab Digitalization Loop Picks up Speed
12 Dec 2018,
- 6th Annual Open Meeting Pharmacogeneitcs and Stratified Medicine Network
06 Mar 2019, Regents Park